Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evaluation of once daily sotalol administration in man.

Literature DB >> 861130

Evaluation of once daily sotalol administration in man.

D G McDewitt, R G Shanks.

Abstract

Entities: Chemical Species

Mesh：

Substances：
Sotalol

Year: 1977 PMID： 861130 PMCID： PMC1429014 DOI： 10.1111/j.1365-2125.1977.tb00687.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

4 in total

1. Observations on the efficacy and pharmacokinetics of sotalol after oral administration.

Authors: H C Brown; S G Carruthers; J G Kelly; D G McDevitt; R G Shanks
Journal: Eur J Clin Pharmacol Date: 1976-03-22 Impact factor: 2.953

2. Blood levels of drug at the equilibrium state after multiple dosing.

Authors: J G Wagner; J I Northam; C D Alway; O S Carpenter
Journal: Nature Date: 1965-09-18 Impact factor: 49.962

3. Different effects of adrenergic beta-receptor blockade on heart rate response to mental stress, catecholamines, and exercise.

Authors: S H Taylor; M K Meeran
Journal: Br Med J Date: 1973-11-03

4. The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.

Authors: T B Tjandramaga; R Verbeeck; J Thomas; R Verbesselt; R Verberckmoes; P J Schepper
Journal: Br J Clin Pharmacol Date: 1976-04 Impact factor: 4.335

4 in total

11 in total

1. Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors: D G McDevitt
Journal: Drugs Date: 1979-04 Impact factor: 9.546

2. Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol.

Authors: W J Leahey; J D Neill; M P Varma; R G Shanks
Journal: Br J Clin Pharmacol Date: 1980-01 Impact factor: 4.335

3. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol.

Authors: M J Kendall; V A John; C P Quarterman; P G Welling
Journal: Eur J Clin Pharmacol Date: 1980-02 Impact factor: 2.953

4. Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol.

Authors: W J Leahey; J D Neill; M P Varma; R G Shanks
Journal: Eur J Clin Pharmacol Date: 1980-06 Impact factor: 2.953

Evaluation of once daily sotalol administration in man.

1. Observations on the efficacy and pharmacokinetics of sotalol after oral administration.

2. Blood levels of drug at the equilibrium state after multiple dosing.

3. Different effects of adrenergic beta-receptor blockade on heart rate response to mental stress, catecholamines, and exercise.

4. The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.

1. Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

2. Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol.

3. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol.

4. Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol.

Review 5. Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

6. Comparison of once and twice daily administration of sotalol in the treatment of hypertension.

Review 7. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

8. Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiency.

9. Pharmacokinetics of sotalol during pregnancy.

10. Comparison of once and twice daily sotalol in exercise-induced angina pectoris.